In just under three months of trading, VIDI has fallen behind IXUS by almost 300 basis points. Yet it has also outperformed the iShares MSCI Emerging Markets ETF (EEM) by 350 basis points.
A three-month window of underperformance does not invalidate the strategy. But it does make the point that no smart-beta fund will outperform its market-cap weighted benchmark all the time. Smart beta may seek to add value, but of course there is no guarantee of outperformance.
VUSE may get off to a great start or a lousy start, but any investor considering a smart-beta product needs to be able to stick to a long-term investment horizon. Giving up on a broad-based fund after a few months would simply be time wasted.
At the time of publication, the author held no positions in any of the stocks mentioned.Follow @randomroger This article represents the opinion of a contributor and not necessarily that of TheStreet or its editorial staff.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV